{
    "code": 0,
    "data": [
        {
            "sym": "ANTHEM",
            "disp": "Anthem Biosciences",
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript for Q3 FY26",
            "news_id": "218c6c48-4245-4e02-a640-ce06b8e99952",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51338f86-b191-4a62-a100-0cca33a3b3dc.pdf",
            "news_date": "2026-02-09 16:31:51",
            "seo": "anthem-biosciencesltd",
            "ltp": 692.15,
            "ch": 15.449999999999932,
            "pch": 2.2831387616373475,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 757885,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript for Q3 FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51338f86-b191-4a62-a100-0cca33a3b3dc.pdf",
            "news_date": "2026-02-09 16:31:51"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication of Financial Results for the quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=865d525f-8943-4387-b6e2-bfa20b7bd9f8.pdf",
            "news_date": "2026-02-06 12:37:21"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release (Revised)",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)",
            "news_body": "Submission of revised press release for the quarter and nine months ended December 31 2025 in machine readable format",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=528b9f75-eb20-473a-ba02-d9597f12d6e5.pdf",
            "news_date": "2026-02-05 19:38:33"
        },
        {
            "sym": "ANTHEM",
            "disp": "Anthem Biosciences",
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Submission of audio recordings of Earnings Call for the quarter and nine months ended December 31 2025",
            "news_id": "483dc622-761d-471e-a56f-eaa9919d4679",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b58b6cb9-6257-4321-9e00-9cc232d5dc02.pdf",
            "news_date": "2026-02-05 18:03:10",
            "seo": "anthem-biosciencesltd",
            "ltp": 692.15,
            "ch": 15.449999999999932,
            "pch": 2.2831387616373475,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 757885,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Submission of audio recordings of Earnings Call for the quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b58b6cb9-6257-4321-9e00-9cc232d5dc02.pdf",
            "news_date": "2026-02-05 18:03:10"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Allotment of 103800 equity shares of face value Rs. 2 each pursuant to the exercise of ESOP Options under Anthem Employee Stock Option Plan 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f152fc1d-77da-42b2-ab9c-994e32a9242c.pdf",
            "news_date": "2026-02-05 14:30:05"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release (Revised)",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)",
            "news_body": "Submission of revised Press Release for the Financial Results for the quarter and nine months ended December 31 2025 due to inadvertent missing on the complete press release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6df9984d-f68c-4175-b89c-e8281d998211.pdf",
            "news_date": "2026-02-05 14:26:13"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press release for the financial results for the quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dda89050-f4b9-4cfd-abb3-eca6b3b2551e.pdf",
            "news_date": "2026-02-05 13:48:03"
        },
        {
            "sym": "ANTHEM",
            "disp": "Anthem Biosciences",
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Submission of Investor Presentation for the quarter and nine months ended December 31 2025",
            "news_id": "11a655c1-766d-4a14-85b8-acee74d4492f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1bb2c5d7-de77-42f2-8db1-ba1ea7daa022.pdf",
            "news_date": "2026-02-05 13:33:43",
            "seo": "anthem-biosciencesltd",
            "ltp": 692.15,
            "ch": 15.449999999999932,
            "pch": 2.2831387616373475,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 757885,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Submission of Investor Presentation for the quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1bb2c5d7-de77-42f2-8db1-ba1ea7daa022.pdf",
            "news_date": "2026-02-05 13:33:43"
        },
        {
            "sym": "ANTHEM",
            "disp": "Anthem Biosciences",
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Submission of financial results for the quarter and nine months ended December 31 2025",
            "news_id": "31993ce2-b717-4180-875d-0871274022f1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=877d0b85-d078-4156-a119-6ea72614b4a0.pdf",
            "news_date": "2026-02-05 13:25:06",
            "seo": "anthem-biosciencesltd",
            "ltp": 692.15,
            "ch": 15.449999999999932,
            "pch": 2.2831387616373475,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 757885,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Submission of financial results for the quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=877d0b85-d078-4156-a119-6ea72614b4a0.pdf",
            "news_date": "2026-02-05 13:25:06"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday February 05 2026",
            "news_body": "Submission of Unaudited Standalone and Consolidated Financial Results with Limited Review Report of Statutory Auditors for the quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f12b071-75f3-4001-9eee-d56120a2d5a6.pdf",
            "news_date": "2026-02-05 13:14:08"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Revised Earnings Conference Call to discuss the unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70634e1a-2ece-4090-bb7a-36f546bb4b81.pdf",
            "news_date": "2026-01-27 22:18:34"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that an Earnings Conference Call to discuss the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2025 is scheduled on Thursday February 05 2026 at 02:30 PM IST/ 04:00 AM USA / 09:00 AM UK / 05:00 PM SGT/HKT.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a5c35df-c127-4782-bc85-3104ff011ac8.pdf",
            "news_date": "2026-01-27 17:46:33"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Intimation For Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Anthem Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 inter alia to consider and approve This is to inform you that pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 a meeting of the Board of Directors of Anthem Biosciences Limited (the Company) is scheduled to be held on Thursday February 05 2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b3c33df-3660-4a37-8712-0f650c642c4c.pdf",
            "news_date": "2026-01-27 17:37:49"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Compliance Certificate Under Regulation 74(5) Of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29971af0-8735-4adf-8a53-7dc632cb09af.pdf",
            "news_date": "2026-01-07 16:26:47"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of SEBI LODR Regulations With Reference To Issuance Of Corporate Guarantee",
            "news_body": "Issuance of Corporate Guarantee in favor of Citi Bank N.A and Federal Bank Limited amounting to Rs. 25 Crores and 24 Crores Respectively on behalf of Neoanthem Lifesciences Limited (Wholly Owned Subsidiary) for availing the various fund based Working Capital Credit facility availed by Wholly Owned Subsidiary",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3149cf4-5c17-4925-934d-72cb645c51e8.pdf",
            "news_date": "2026-01-07 14:18:13"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading Window for consideration of Financial Results for the quarter ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d67af6e3-f1ac-464e-b098-df66a95e1052.pdf",
            "news_date": "2025-12-29 16:21:17"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation for Schedule of Analyst/Investor Meet",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ceafeca-a814-4dcc-b456-94b0fe0b9c7f.pdf",
            "news_date": "2025-12-15 15:06:34"
        },
        {
            "sym": "ANTHEM",
            "disp": "Anthem Biosciences",
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript for the financial result of quarter and half year ended September 30 2025",
            "news_id": "a72e724e-32a2-422f-a0a4-b051e71bbcbc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2e49a19-a719-4d38-8a83-28d377e4e844.pdf",
            "news_date": "2025-11-12 18:19:26",
            "seo": "anthem-biosciencesltd",
            "ltp": 692.15,
            "ch": 15.449999999999932,
            "pch": 2.2831387616373475,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 757885,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript for the financial result of quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2e49a19-a719-4d38-8a83-28d377e4e844.pdf",
            "news_date": "2025-11-12 18:19:26"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Violation Under CompanyS Code Of Conduct To Regulate Monitor And Report Trading By Designated Persons As Required Under SEBI (Prohibition Of Insider Trading) Regulations 2015 (SEBI PIT Regulations)",
            "news_body": "Intimation of Action Taken report for violation of Companys Code of Conduct on Insider Trading Regulation.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e1a7164-2384-4ff6-80c5-09a4f944dc00.pdf",
            "news_date": "2025-11-11 12:21:14"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication of Financial Result for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f22b05ef-1d12-4868-87c8-b7e124859d9b.pdf",
            "news_date": "2025-11-10 17:13:27"
        },
        {
            "sym": "ANTHEM",
            "disp": "Anthem Biosciences",
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recordings of Earnings Call for the quarter and half year ended September 30 2025",
            "news_id": "79da1499-991b-4561-831e-f848a62c9b20",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=95f391b1-406a-4214-8b74-730ccbc5768d.pdf",
            "news_date": "2025-11-10 16:47:47",
            "seo": "anthem-biosciencesltd",
            "ltp": 692.15,
            "ch": 15.449999999999932,
            "pch": 2.2831387616373475,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 757885,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recordings of Earnings Call for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=95f391b1-406a-4214-8b74-730ccbc5768d.pdf",
            "news_date": "2025-11-10 16:47:47"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press release for the financial result for quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af0ebdb3-314e-44ed-8a0c-4beded3c8935.pdf",
            "news_date": "2025-11-08 21:03:29"
        },
        {
            "sym": "ANTHEM",
            "disp": "Anthem Biosciences",
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation for the financial results for quarter and half year ended September 30 2025.",
            "news_id": "e54000a6-2bc6-476e-9a63-50bf44d270b4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b25f96c-2dc4-4879-94d3-42e991e95d82.pdf",
            "news_date": "2025-11-08 21:01:49",
            "seo": "anthem-biosciencesltd",
            "ltp": 692.15,
            "ch": 15.449999999999932,
            "pch": 2.2831387616373475,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 757885,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation for the financial results for quarter and half year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b25f96c-2dc4-4879-94d3-42e991e95d82.pdf",
            "news_date": "2025-11-08 21:01:49"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday November 08 2025",
            "news_body": "Submission of Unaudited Standalone and Consolidated Financial Results along with Limited Review Report of Statutory Auditors for the quarter and half year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22c024f0-c766-4001-9b76-aa1703437ccb.pdf",
            "news_date": "2025-11-08 20:05:08"
        },
        {
            "sym": "ANTHEM",
            "disp": "Anthem Biosciences",
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Saturday November 08 2025",
            "news_body": "Unaudited financial results for quarter and half year ended September 30 2025.",
            "news_id": "10c2ac14-5019-48cd-91a8-1ce5439771c1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb7bc415-18ef-4e73-9dd3-d86067a458b3.pdf",
            "news_date": "2025-11-08 20:00:34",
            "seo": "anthem-biosciencesltd",
            "ltp": 692.15,
            "ch": 15.449999999999932,
            "pch": 2.2831387616373475,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 757885,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Saturday November 08 2025",
            "news_body": "Unaudited financial results for quarter and half year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb7bc415-18ef-4e73-9dd3-d86067a458b3.pdf",
            "news_date": "2025-11-08 20:00:34"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Violation Under CompanyS Code Of Conduct To Regulate Monitor And Report Trading By Designated Persons As Required Under SEBI (Prohibition Of Insider Trading) Regulations 2015 (SEBI PIT Regulations)",
            "news_body": "Violation of Company Code of conduct to regulate Monitor and Report trading by Designated persons.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e975db7-799b-4d70-b3e1-ca9913caeb75.pdf",
            "news_date": "2025-10-28 19:59:10"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that an Earnings Conference Call to discuss the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30 2025 is scheduled for Monday November 10 2025 at 12:00 PM IST/ 14:30 SGT/HKT.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=373732e6-6b90-456c-8b68-e3d6113e062c.pdf",
            "news_date": "2025-10-23 20:04:19"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for The Financial Results For Quarter And Half Year Ended September 30 2025",
            "news_body": "Anthem Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 inter alia to consider and approve This is to inform you that pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 a meeting of the Board of Directors of Anthem Biosciences Limited (the Company) is scheduled to be held on Saturday November 08 2025 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0d73038e-826f-4f28-951c-928fc19095c3.pdf",
            "news_date": "2025-10-23 19:57:11"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74(5) of SEBI Depositories and Participants) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0d6a5d0c-b421-49af-87a6-931c5b367ccc.pdf",
            "news_date": "2025-10-06 17:09:22"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Closure of Trading Window for Q2 of FY 2025 - 26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2993b9ed-a804-4180-8193-87929e154e2a.pdf",
            "news_date": "2025-09-29 11:55:24"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst Meet under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3164135d-30b3-4375-96a3-814ba2a45202.pdf",
            "news_date": "2025-09-19 15:50:37"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "Voting Results along with scrutinizer report for postal ballot through remote e-voting process",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=004c1e43-0522-4b6c-9055-35b7f7db202a.pdf",
            "news_date": "2025-09-15 20:53:33"
        },
        {
            "sym": "ANTHEM",
            "disp": "Anthem Biosciences",
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcripts for the Quarter ended June 30 2025",
            "news_id": "da1e3674-eed1-431c-bffe-33613d771308",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6642b948-ce4f-437e-87fa-cc6b98e18b80.pdf",
            "news_date": "2025-08-18 16:07:44",
            "seo": "anthem-biosciencesltd",
            "ltp": 692.15,
            "ch": 15.449999999999932,
            "pch": 2.2831387616373475,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 757885,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcripts for the Quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6642b948-ce4f-437e-87fa-cc6b98e18b80.pdf",
            "news_date": "2025-08-18 16:07:44"
        },
        {
            "sym": "ANTHEM",
            "disp": "Anthem Biosciences",
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call for the quarter ended June 30 2025",
            "news_id": "95241e39-d5d1-4c2c-8b86-921c9f39ceb0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03bfc7c8-35d9-44fa-add2-0f8b1999d9d9.pdf",
            "news_date": "2025-08-14 15:56:48",
            "seo": "anthem-biosciencesltd",
            "ltp": 692.15,
            "ch": 15.449999999999932,
            "pch": 2.2831387616373475,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 757885,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03bfc7c8-35d9-44fa-add2-0f8b1999d9d9.pdf",
            "news_date": "2025-08-14 15:56:48"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper advertisement confirming dispatch of Postal Ballot Notice",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ebe91c3f-f0c0-4b5d-a59d-ea271e9eddc7.pdf",
            "news_date": "2025-08-14 15:46:08"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement - Unaudited Consolidated and Standalone Financial Results for the Quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46cad9d3-ffed-41b5-96a6-d436970db223.pdf",
            "news_date": "2025-08-14 15:42:02"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Please fine enclosed herewith Notice of Postal Ballot dated August 13 2025 seeking approval of members for the resolution stated therein",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a64962a3-1d0c-41b4-9161-6712f3b00057.pdf",
            "news_date": "2025-08-13 21:58:50"
        },
        {
            "sym": "ANTHEM",
            "disp": "Anthem Biosciences",
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Unaudited Consolidated Financial Statement for the Quarter ended June 30 2025",
            "news_id": "7e248f44-9cc0-4c8e-8746-100b32af06ee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3702497f-5880-4170-b1c1-c52828d3c96f.pdf",
            "news_date": "2025-08-13 21:16:32",
            "seo": "anthem-biosciencesltd",
            "ltp": 692.15,
            "ch": 15.449999999999932,
            "pch": 2.2831387616373475,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 757885,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Unaudited Consolidated Financial Statement for the Quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3702497f-5880-4170-b1c1-c52828d3c96f.pdf",
            "news_date": "2025-08-13 21:16:32"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press release on the Unaudited Consolidated Financial Results for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51cbb8f8-cff0-4b03-81c5-9a9b75abea1a.pdf",
            "news_date": "2025-08-13 21:11:04"
        },
        {
            "sym": "ANTHEM",
            "disp": "Anthem Biosciences",
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On Wednesday August 13 2025",
            "news_body": "We would like to inform that Board at its meeting held today have approved financial results of the Company for the Quarter ended June 30 2025",
            "news_id": "afa1ecc8-1f4e-46ba-8a5c-a72823bdc501",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58cd8e1b-c373-4759-9b9c-0b0bb305d59a.pdf",
            "news_date": "2025-08-13 20:47:56",
            "seo": "anthem-biosciencesltd",
            "ltp": 692.15,
            "ch": 15.449999999999932,
            "pch": 2.2831387616373475,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 757885,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On Wednesday August 13 2025",
            "news_body": "We would like to inform that Board at its meeting held today have approved financial results of the Company for the Quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58cd8e1b-c373-4759-9b9c-0b0bb305d59a.pdf",
            "news_date": "2025-08-13 20:47:56"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday August 13 2025",
            "news_body": "Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI LODR) we would like to inform you that the Board of Directors of Anthem Biosciences Limited (formerly known as Anthem Biosciences Private Limited) (\"Company\") at their meeting held on Wednesday August 13 2025 have approved the financials results for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3578ac2d-4b0f-40a1-8507-639963b4e30d.pdf",
            "news_date": "2025-08-13 20:25:19"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that an Earnings Conference Call to discuss the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2025 is scheduled for Thursday August 14 2025 at 12:00 PM IST/ 14:30 SGT/HKT.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14743587-f448-4de2-b64d-ab39f52c37db.pdf",
            "news_date": "2025-08-08 18:16:05"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Considering And Approval Of The Unaudited Financial Results For The Quarter Ended June 30 2025",
            "news_body": "Anthem Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve Unaudited Financial Results of the Company for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc357c37-3f4e-4266-80ef-b5b11be5548b.pdf",
            "news_date": "2025-08-08 17:46:45"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30(5) Of The Securities And Exchange Board Of India (Listing Obligation And Disclosures Requirements) Regulation 2015",
            "news_body": "Names of the Key Managerial Personnels of the Company who are authorised to determine the materiality of an event or information and for the purpose of making disclosure to the stock exchanges under Regulation30 of SEBI (Listing Obligations Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df3eaff9-a826-4c18-b4cc-f272d1726351.pdf",
            "news_date": "2025-07-21 16:33:49"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 7(1) Of The Securities And Exchange Board Of India (Listing Obligation And Disclosures Requirements) Regulation 2015",
            "news_body": "Intimation of continuation of Kfin Technologies Limited as the Registrar and Share Transfer Agent of Anthem Biosciences Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5dd70e8b-6d35-4983-855d-aea4a7ea5c3f.pdf",
            "news_date": "2025-07-21 16:26:26"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Code of Conduct under SEBI (PIT) Regulations 2015",
            "caption": "Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015",
            "news_body": "Intimation under Regulation 8(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a394b5e-d5e7-43cc-b59b-ade905e3ab30.pdf",
            "news_date": "2025-07-21 16:17:32"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Trading Window Closure",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f19a77ad-8449-403c-9806-58c6232f5503.pdf",
            "news_date": "2025-07-21 16:09:23"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General_Announcements",
            "descriptor": "Appointment of Company Secretary / Compliance Officer",
            "caption": "Appointment of Company Secretary and Compliance Officer",
            "news_body": "Intimation of continuation of Ms. Divya Prasad as the Compliance Officer of Anthem Biosciences Limited pursuant to Regulation 6(1) of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e954109f-4922-402e-9268-48bcb21ffe7f.pdf",
            "news_date": "2025-07-21 16:03:09"
        },
        {
            "co_code": 33976,
            "bse_code": 544449,
            "isin": "INE0CZ201020",
            "ann_type": "General",
            "descriptor": "New Listing",
            "caption": "Listing of Equity Shares of Anthem Biosciences Ltd",
            "news_body": "Trading Members of the Exchange are hereby informed that effective from July 21 2025 the equity shares of Anthem Biosciences Ltd (Scrip Code: 544449) are listed and admitted to dealings on the Exchange in the list of B Group Securities. For further details please refer to the notice no. 20250718-44 dated July 18 2025.",
            "file_url": "",
            "news_date": "2025-07-21 08:06:02"
        }
    ]
}